Cargando…

SIRPα on Mouse B1 Cells Restricts Lymphoid Tissue Migration and Natural Antibody Production

The inhibitory immunoreceptor SIRPα is expressed on myeloid and neuronal cells and interacts with the broadly expressed CD47. CD47-SIRPα interactions form an innate immune checkpoint and its targeting has shown promising results in cancer patients. Here, we report expression of SIRPα on B1 lymphocyt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Franke, Katka, Pillai, Saravanan Y., Hoogenboezem, Mark, Gijbels, Marion J. J., Matlung, Hanke L., Geissler, Judy, Olsman, Hugo, Pottgens, Chantal, van Gorp, Patrick J., Ozsvar-Kozma, Maria, Saito, Yasuyuki, Matozaki, Takashi, Kuijpers, Taco W., Hendriks, Rudi W., Kraal, Georg, Binder, Christoph J., de Winther, Menno P. J., van den Berg, Timo K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7581795/ https://www.ncbi.nlm.nih.gov/pubmed/33162986 http://dx.doi.org/10.3389/fimmu.2020.570963

Ejemplares similares

CD47-SIRPα Checkpoint Inhibition Enhances Neutrophil-Mediated Killing of Dinutuximab-Opsonized Neuroblastoma Cells
por: Martínez-Sanz, Paula, et al.
Publicado: (2021)

Immunoreceptors on neutrophils
por: van Rees, Dieke J., et al.
Publicado: (2016)

BYON4228 is a pan-allelic antagonistic SIRPα antibody that potentiates destruction of antibody-opsonized tumor cells and lacks binding to SIRPγ on T cells
por: van Helden, Mary J, et al.
Publicado: (2023)

Absence of p55 TNF Receptor Reduces Atherosclerosis, but Has No Major Effect on Angiotensin II Induced Aneurysms in LDL Receptor Deficient Mice
por: Xanthoulea, Sofia, et al.
Publicado: (2009)

Sodium stibogluconate and CD47-SIRPα blockade overcome resistance of anti-CD20–opsonized B cells to neutrophil killing
por: van Rees, Dieke J., et al.
Publicado: (2022)

Regulation of Phagocyte Migration by Signal Regulatory Protein-Alpha Signaling
por: Alvarez-Zarate, Julian, et al.
Publicado: (2015)

Anticancer efficacy of monotherapy with antibodies to SIRPα/SIRPβ1 mediated by induction of antitumorigenic macrophages
por: Sakamoto, Mariko, et al.
Publicado: (2021)

Efficient complement-mediated clearance of immunosuppressed T cells by macrophages
por: Gankema, Angela A. F., et al.
Publicado: (2023)

Humanized MISTRG as a preclinical in vivo model to study human neutrophil-mediated immune processes
por: Martinez-Sanz, Paula, et al.
Publicado: (2023)

Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and target for cancer immunotherapy
por: Logtenberg, Meike E. W., et al.
Publicado: (2019)

Prion pathogenesis is unaltered in the absence of SIRPα-mediated "don't-eat-me" signaling
por: Nuvolone, Mario, et al.
Publicado: (2017)

Anti‐human SIRPα antibody is a new tool for cancer immunotherapy
por: Murata, Yoji, et al.
Publicado: (2018)

G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment
por: Martinez Sanz, Paula, et al.
Publicado: (2021)

Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis
por: Okamoto, Takeshi, et al.
Publicado: (2023)

Hematopoietic miR155 Deficiency Enhances Atherosclerosis and Decreases Plaque Stability in Hyperlipidemic Mice
por: Donners, Marjo M. P. C., et al.
Publicado: (2012)

Non-Hematopoietic and Hematopoietic SIRPα Signaling Differently Regulates Murine B Cell Maturation in Bone Marrow and Spleen
por: Kolan, Shrikant Shantilal, et al.
Publicado: (2015)

Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al
por: Martinez Sanz, Paula, et al.
Publicado: (2021)

Plasticity in Pro- and Anti-tumor Activity of Neutrophils: Shifting the Balance
por: Furumaya, Charita, et al.
Publicado: (2020)

FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils
por: Treffers, Louise W., et al.
Publicado: (2019)

Deletion of SIRPα (signal regulatory protein-α) promotes phagocytic clearance of myelin debris in Wallerian degeneration, axon regeneration, and recovery from nerve injury
por: Elberg, Gerard, et al.
Publicado: (2019)

Targeting SIRPα in cancer
por: Ho, Jenny M., et al.
Publicado: (2013)

Myeloid Ezh2 Deficiency Limits Atherosclerosis Development
por: Neele, Annette E., et al.
Publicado: (2021)

Lack of eosinophil extracellular trap formation due to failure of plasma membrane breakdown in the absence of elastase
por: Sprenkeler, Evelien G. G., et al.
Publicado: (2023)

Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint
por: Voets, Erik, et al.
Publicado: (2019)

CD47–SIRPα-targeted therapeutics: status and prospects
por: Maute, R., et al.
Publicado: (2022)

CD47/SIRPα axis: bridging innate and adaptive immunity
por: van Duijn, Anneloes, et al.
Publicado: (2022)

The Effect of a 13-Valent Conjugate Pneumococcal Vaccine on Circulating Antibodies Against Oxidized LDL and Phosphorylcholine in Man, A Randomized Placebo-Controlled Clinical Trial
por: Grievink, Hendrika W., et al.
Publicado: (2020)

Microglial SIRPα regulates the emergence of CD11c(+) microglia and demyelination damage in white matter
por: Sato-Hashimoto, Miho, et al.
Publicado: (2019)

Cancer cells under immune attack acquire CD47-mediated adaptive immune resistance independent of the myeloid CD47-SIRPα axis
por: Hendriks, Mark A.J.M., et al.
Publicado: (2021)

Synapse Maturation by Activity-Dependent Ectodomain Shedding of SIRPα
por: Toth, Anna B., et al.
Publicado: (2013)

β2 Integrin Signaling Cascade in Neutrophils: More Than a Single Function
por: Bouti, Panagiota, et al.
Publicado: (2021)

OX130 Monoclonal Antibody Recognizes Human SIRPβ1 but Cross-Reacts on SIRPα from One Allele
por: Hatherley, Deborah, et al.
Publicado: (2016)

SBDS Expression and Localization at the Mitotic Spindle in Human Myeloid Progenitors
por: Orelio, Claudia, et al.
Publicado: (2009)

Engagement of SIRPα Inhibits Growth and Induces Programmed Cell Death in Acute Myeloid Leukemia Cells
por: Irandoust, Mahban, et al.
Publicado: (2013)

CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab
por: van Bommel, Peter E., et al.
Publicado: (2017)

Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice
por: Delsing, Dianne J.M, et al.
Publicado: (2011)

High immunoglobulin-M levels to oxidation-specific epitopes are associated with lower risk of acute myocardial infarction
por: Taleb, Adam, et al.
Publicado: (2023)

Educational paper: Defects in number and function of neutrophilic granulocytes causing primary immunodeficiency
por: van den Berg, J. Merlijn, et al.
Publicado: (2011)

Cancer Therapy Targeting CD47/SIRPα
por: Dizman, Nazli, et al.
Publicado: (2021)

CD47‐SIRPα blocking‐based immunotherapy: Current and prospective therapeutic strategies
por: Bouwstra, Renée, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f4gv1vi88dl5ij2cs6mibf95bu